Malaria is a pathogenic infection caused by protozoa of the genus plasmodium. It is mainly confi ned to sub-Saharan Africa, Asia and South America. This disease claims the life of over 1.5 to 2.7 million people per year. Owing to such a high incidence of malarial infections, there is an urgent need for the development of suitable vaccines. For the development of ideal vaccines, it is essential to understand the molecular mechanisms of malarial pathogenesis and the factors that lead to malaria infection. Genetic factors have been proposed to play an important role in malarial pathogenesis. Complement receptor 1 (CR1) is an important host red blood cell protein involved in interaction with malarial parasite. Various polymorphic forms of CR1 have been found to be involved in conferring protection or increasing susceptibility to malaria infections. Low-density allele (L) of CR1 gave contradictory results in different set of studies. In addition, Knops polymorphic forms Sl (a + ) and McC (a) have been found to contribute more towards the occurrence of cerebral malaria in malaria endemic regions compared to individuals with Sl (a -) / McC (a/b) genotype. This article reviews the research currently going on in this area and throws light on as yet unresolved mysteries of the role of CR1 in malarial pathogenesis.
Key words: Complement receptor 1, Knops polymorphism, Plasmodium falciparum erythrocyte membrane protein 1 phenotype termed as rosetting, causes clumps of erythrocytes and brings about vascular obstruction and impaired tissue perfusion. [2] This property has been associated with severe malaria. [3, 4] Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)
has been found to be the protein involved in rosetting [5.6] and CR1 is the associated host counterpart. [7] PfEMP1 is an adhesion protein encoded by the large and diverse var gene family that is involved in clonal antigenic variation and plays a central role in P.
falciparum pathogenesis. [8, 9] The extra-cellular portion Density polymorphism (determined by alleles H for high and L for low expression on erythrocyte surface), [13.14] Structural polymorphism (differences in molecular weight and D) [13.15.16] and Knops blood group polymorphism.
[17] 
Characteristics of Plasmodium infection
Plasmodium falciparum causes the most deadly and severe infections. [22, 23] It infects all ages of RBCs, leading to a higher parasitemia. Mature trophozoites and schizonts are sequestered in the microvascular system leading to tissue ischemia. [22] A schematic representation of the life cycle of malarial parasite is depicted in Figure   1 . The problem of spread of infections becomes all the more acute because of widespread drug resistance in P. falciparum infections. [24, 25] Plasmodium vivax usually does not cause lifethreatening infections. It only infects reticulocytes and produces hypnozoites, which are latent in the liver.
Relapses can occur up to 5 years after infection.
[26] The parasite uses the Duffy blood receptor to enter RBCs;
hence Duffy negative individuals are not infected by this species.
[27]
Epidemiology of malaria
Malaria was fi rst documented in 1700 B.C.
[28] 40% of the world's population lives in areas where there is a risk of acquiring this disease. Worldwide, an estimated 300-500 million people contract malaria each year, resulting in 1.5-2.7 million deaths annually. [29, 30] About 90% of these cases are from tropical Africa; remaining cases are reported from Brazil, India and Sri Lanka. India alone contributes 80% of the victims.
[31] 0.1 million of these are children below the age of 5 years. [32] In endemic areas, infected children show symptoms between 4 to 8 months of age. Symptoms include fever, irritability, poor feeding, vomiting, diarrhea and convulsions. In most of the cases the infection is limited to recurring episodes of fever, chills and shakes and can be controlled with proper medication.
However in some of the individuals severe malaria can precipitate due to variety of factors including genetic, environmental, socio-economic status of individuals. It has now been realized that treatment or prevention of malaria is only possible through identifi cation of these factors. In particular, greater emphasis is now being laid on identifying the host genetic factors involved in malaria pathogenesis.
Genetic factors in malaria pathogenesis: Host genes involved in malaria
Polymorphic forms of a number of host genes involved in immunity have been associated with protection or susceptibility to malaria. The most plausible candidates include hemoglobin variants, Duffy blood group antigen variants, glucose-6-phosphate dehydrogenase, histocompatibilty genes, tumor necrosis factor-α, ICAM-1, nitric oxide synthase promoter region (NOS 2).
[33]
Other candidate genes include CR1, which is involved in erythrocyte rosetting and thrombospondin receptor CD36, which mediates parasite binding to endothelium and also possibly to dendritic cells. [33.34] The candidate genes and their plausible role in malaria pathogenesis are listed in Table 1 .
Rosetting of P. falciparum infected erythrocytes
Plasmodium falciparum virulence phenotype is a major area of research these days. This phenotype termed as rosetting [2] causes clumps of cells and brings about
Gandhi: CR1 and the molecular pathogenesis of malaria Figure 2 ]. [35, 36] Peripheral sequestration also protects Plasmodium falciparum from being sequestered in the spleen.
It has been found that rosetting of erythrocytes is associated with the occurrence of severe malaria, subsequently; a role for PfEMP1 in rosetting was suggested.
[5.6] CR1 has been found to be the associated host counterpart for mediating the clumping of uninfected erythrocytes.
[7]
Complement receptor 1 and rosetting CR1 is a 200-kDa single chain membrane bound glycoprotein and a member of the regulators of complement activation (RCA) gene cluster. CR1
possesses complex tri and tetra N-linked oligosaccharides in its mature form and the gene for this protein is located on the q32 arm of chromosome 1. [37, 38] It is composed of a number of repeated domains called short consensus repeats (SCRs) each of which is composed of 60 amino acids containing four invariant cysteines.
[39] The extracellular domain of the CR1 is composed of 30 SCRs, the fi rst 28 of which are arranged in tandem repeats in homologous groups of 7, with each group known as long homologous repeat (LHR).
[38] SCRs 8-12 and SCRs 15-18 preferentially bind to C3b and SCRs 1-4 preferentially bind to C4b. [38.39] The region of CR1 that interacts with infected erythrocytes to form rosettes has been mapped to LHR-B and fi rst three SCRs of LHR-C, SCR 10 and 17 have been particularly found to play an important role in this interaction.
[37]
Effect of differential CR1 expression on malarial pathogenesis
Erythrocytes infected with P. falciparum rosette effi ciently with uninfected erythrocytes that have normal copy number of CR1, but not with cells in which the number <60. [7] As the number of CR1 molecules on RBCs increases, so does their propensity to form rosettes. [7] Rosette formation is inhibited by sCR1. [7] Differences in the expression of CR1 on erythrocytes might determine susceptibility of an individual towards development of cerebral malaria and severe malaria-associated anemia.
In one of the studies it was suggested that young children may be more susceptible to SMA because of their lower levels of RBC complement regulatory proteins, which make them less equipped to handle IC formation and complement activation. [40] Previously same group of researchers had proved that a decline in levels of CR1 and increase in immune complex levels signifi cantly associates with SMA. correlates with CR1 copy number on erythrocytes.
[13]
Homozygotes for the L (low expression) allele usually express fewer than 200 copies of CR1, homozygotes for the H (high expression) allele express several times this number and heterozygotes are intermediate. [13] This polymorphism arises due to a single base change in the intron of d1d2 segment within the LHR-D (Long and 8% respectively. Gene frequencies for H and L alleles in this study were 0.77 and 0.23 respectively.
HH had been found to be the predominant form in this study. [54]
Data from India however, is still not available on this aspect of CR1 polymorphism and we are investigating the distribution of Knops polymorphic forms of CR1 in the Indian population.
Out of the three polymorphic forms, size polymorphism has not been found to play a role in determining susceptibility to severe malaria. With regard to density polymorphism, some studies suggest that low-density allele confers protection against malaria [18] whereas another [19] suggested that low-density allele might be a risk factor for severe forms of malaria. Erythrocytes with low CR1 expression (because of the homozygous LL genotype of CR1) have been shown to form reduced number of rosettes with Plasmodium falciparum infected cells. [55] In Africa, rosetting has been shown to correlate with disease severity. [3] Since erythrocytes having low CR1 form fewer rosettes, it has been postulated that low E-CR1 might protect from severe malaria.
Recently, Cockburn et al. suggested [17] and hence suggested to be protective against rosetting and severe malaria.
The role of these polymorphic forms in affecting the rosette formation has also been investigated. [18.53] Knops phenotype Sl (a -) has been found to rosette less effi ciently than Sl(a+) and hence suggested to be more protective.
[ Monoclonal antibodies can be developed, that can reverse rosette formation in patients of SMA. However, in order to achieve any of these desired targets, it is absolutely essential to get a more thorough understanding of the interaction of CR1 with PfEMP1 and the role of CR1 polymorphisms in malarial pathogenesis.
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